Immuneering Corp (IMRX) Hedge Fund Ownership (Q2 2026)

Immuneering Corp (IMRX)

108 + Investors. Track Smart Money conviction in IMRX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — IMRX

Based on 111 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 5 quarters in a row

last 6Q

For 5 consecutive quarters, more hedge funds added IMRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

111 hedge funds hold IMRX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +185% more funds vs a year ago

fund count last 6Q

+72 new funds entered over the past year (+185% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 63% buying

76 buying44 selling

Last quarter: 76 funds were net buyers (41 opened a brand new position + 35 added to an existing one). Only 44 were sellers (22 trimmed + 22 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter

Funds opening a new IMRX position: 34 → 32 → 27 → 41. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 30% long-term, 45% new

■ 30% conviction (2yr+) ■ 25% medium ■ 45% new

Of the 111 current holders: 33 (30%) held >2 years, 28 held 1–2 years, and 50 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

➡️

Steady discovery — ~41 new funds/quarter

12 → 34 → 32 → 27 → 41 new funds/Q

New funds entering each quarter: 34 → 32 → 27 → 41. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Veteran-anchored — 43% veterans vs 50% newcomers

■ 43% veterans ■ 7% 1-2yr ■ 50% new

Entry-cohort mix of 116 holders: 50 (43%) are 2+ year veterans, 8 entered 1–2 years ago, and 58 (50%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 63% AUM from top-100 funds

63% from top-100 AUM funds

39 of 110 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in IMRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

5.2

out of 10

Moderate Exit Risk

Exit risk score 5.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	108	92	17.39%
13F Shares	35M	27M	29.47%
Total Value	$163M	$132M	23.26%
New Positions	40	27	+13
Increased Positions	33	29	+4
Closed Positions	23	22	+1
Reduced Positions	20	20	-
Total Calls	3	3	-
Total Puts	3	3	-
PUT/CALL Ratio	1.0	1.0	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

108

17.39%

13F Shares

35M

27M

29.47%

Total Value

$163M

$132M

23.26%

New Positions

+13

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

1.0

Neutral

Institutional Holders (2026 Q2)

108 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMRX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 IMRX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Sanofi	2.53%	2,708,559	$13.5M
2	Alethea Capital Management, LLC	0.98%	472,935	$2.4M
3	DCF Advisers, LLC	0.70%	790,000	$3.9M
4	Occam Crest Management LP	0.59%	278,498	$1.1M
5	Pvg Asset Management Corp	0.42%	146,451	$731K
6	Levin Capital Strategies, L.P.	0.14%	414,000	$2.1M
7	Brandywine Managers, LLC	0.14%	55,066	$275K
8	Flower City Capital	0.12%	55,029	$275K
9	Permanent Capital Management, LP	0.10%	150,000	$748K
10	Kelsey Financial, LLC	0.06%	16,425	$82K
11	Burkehill Global Management, LP	0.05%	300,000	$1.5M
12	Wealth Effects LLC	0.05%	40,100	$200K
13	Future Financial Wealth Managment LLC	0.05%	18,000	$79K
14	Prosight Management, LP	0.03%	36,861	$184K
15	Summit Financial, LLC	0.02%	452,264	$2.3M
16	Thayer Partners, LLC / MA	0.02%	11,000	$55K
17	Palumbo Wealth Management LLC	0.02%	19,083	$95K
18	Berman McAleer LLC	0.01%	25,000	$125K
19	Tidemark, LLC	0.01%	10,000	$50K
20	Bridgeway Capital Management, LLC	0.01%	108,149	$540K
21	Kingsview Wealth Management, LLC	0.01%	123,000	$614K
22	Connor, Clark & Lunn Investment Management Ltd.	0.01%	601,255	$3.0M
23	XTX Topco Ltd	0.00%	64,395	$321K
24	Nations Financial Group Inc, /Ia/ /Adv	0.00%	17,000	$85K
25	China Universal Asset Management Co., Ltd.	0.00%	12,797	$64K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Immuneering Corp (IMRX)

What does the Smart Money Trend signal show for IMRX?

Buying streak — 5 quarters in a row: For 5 consecutive quarters, more hedge funds added IMRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IMRX?

More buyers than sellers — 63% buying: Last quarter: 76 funds were net buyers (41 opened a brand new position + 35 added to an existing one). Only 44 were sellers (22 trimmed + 22 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IMRX holders?

Elite ownership — 63% AUM from top-100 funds: 39 of 110 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in IMRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IMRX?

Mixed — 30% long-term, 45% new: Of the 111 current holders: 33 (30%) held >2 years, 28 held 1–2 years, and 50 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Immuneering Corp (IMRX)

Smart Money Signals — IMRX

Buying streak — 5 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +185% more funds vs a year ago

More buyers than sellers — 63% buying

More new buyers each quarter (+14 vs last Q)

Mixed — 30% long-term, 45% new

Steady discovery — ~41 new funds/quarter

Veteran-anchored — 43% veterans vs 50% newcomers

Elite ownership — 63% AUM from top-100 funds

Institutional Sentiment Summary — IMRX

Hedge Fund Ownership: IMRX

Market Analysis: IMRX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: IMRX

Hedge Fund Positioning: IMRX

Statistics: IMRX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Immuneering Corp (IMRX)

Welcome to 13Foresight!